Co-Amoxi-Mepha 156
Co-Amoxi-Mepha 156 is a medicine authorised by Swissmedic under authorisation number 53982. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 March 2000 and the authorisation is valid without a time limit. ATC code J01CR02 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 53982 |
|---|---|
| Name | Co-Amoxi-Mepha 156 |
| Full name | Co-Amoxi-Mepha 156,25, Pulver zur Herstellung einer Suspension zum Einnehmen |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01CR02 |
| First authorisation | 10 March 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Co-Amoxi-Mepha 156,25, Pulver zur Herstellung einer Suspension zum Einnehmen | A | 10 March 2000 |
| 2 | Co-Amoxi-Mepha 312,5, Pulver zur Herstellung einer Suspension zum Einneh | A | 10 March 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | ml | J01CR02 | 08.01.93 | A |
| 2 | 100 | ml | J01CR02 | 08.01.93 | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Co-Amoxi-Mepha 156 authorised in Switzerland?
Yes. Co-Amoxi-Mepha 156 is authorised by Swissmedic under authorisation number 53982, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Co-Amoxi-Mepha 156 have?
Co-Amoxi-Mepha 156 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Co-Amoxi-Mepha 156?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.